Human CD3E&CD3G/CD3 epsilon&CD3 gamma Protein
Catalog No: CD3EG-HP002
- Species
- Human
- Expression System
- HEK293
- Tag
- an hFc (IgG1)
- Activity
- Activity verified
Product overview
Recombinant Human CD3E&CD3G/CD3 epsilon&CD3 gamma Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus of CD3E and CD3G. It contains amino acid residues Asp23-Asp126 (CD3E) and Gln23-Ser116 (CD3G) (accession: P07766 (CD3E) & P09693 (CD3G)).
Product Details
- Molecular Aliases
- CD3; CD3 epsilon; CD3epsilon; CD3ε; CD3 ε; CD3E; CD3e; CD3 gamma; CD3gamma; CD3γ; CD3 γ; CD3G; CD3g; CD3epsilon&CD3gamma; CD3 epsilon&CD3 gamma; CD3 epsilon & CD3 gamma; CD3ε&CD3γ; CD3 ε&CD3 γ; CD3 ε & CD3 γ; CD3E&CD3G; CD3E & CD3G; CD3 E & CD3 G; CD3e&CD3g; CD3e & CD3g; CD3 e & CD3 g
- Protein Length
- Asp23-Asp126
- Expression System
- HEK293
- Theoretical Molecular Weight
- The protein has a predicted MW of 37.8 kDa (CD3E) and 36.5 kDa (CD3G). Due to glycosylation, the protein migrates to 40-60 kDa based on Bis-Tris PAGE result.
- Purity
- > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
- Endotoxin
- Less than 1 EU per μg by the LAL method.
- Buffer / Formulation
- Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
- State
- Lyophilized
- Storage Conditions
- -20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Reconstitution Advice
- Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.
Data Display
Human CD3E&CD3G/CD3 epsilon&CD3 gamma on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human CD3E&CD3G/CD3 epsilon&CD3 gamma was greater than 95% as determined by SEC-HPLC.
Immobilized Human CD3E&CD3G, hFc Tag at 0.5 μg/ml (100 μl/Well). Dose response curve for Biotinylated Anti-CD3E&CD3G Ab.1, hFc Tag with the EC50 of 1.22 μg/ml determined by ELISA.
Immobilized Human CD3E&CD3G, hFc Tag at 1 μg/ml (100 μl/Well). Dose response curve for Anti-CD3E&CD3G Ab.2, mFc Tag with the EC50 of 20.7 ng/ml determined by ELISA (QC Test).
Immobilized Tebentafusp, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human CD3E&CD3G, hFc Tag with the EC50 of 0.22 μg/ml determined by ELISA.
Background
T-cell surface glycoprotein CD3 epsilon & CD3 gamma chain, also known as CD3E&CD3G, are single-pass type I membrane proteins. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain.
References
- Penaranda C, Tang Q, Bluestone J A. Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells[J]. The Journal of Immunology, 2011, 187(4):2015-2022.
- Gedeon P C, Schaller T H, Chitneni S K, et al. A rationally designed fully human EGFRvIII:CD3-targeted bispecific antibody redirects human T cells to treat patient-derived intracerebral malignant glioma.[J]. Clinical Cancer Research, 2018:clincanres.0126.2017.
Have questions about this product?
Our technical team can help with product selection, application questions and order support.